Protease-Antiprotease Interactions and the Rationale for Therapeutic Protease Inhibitors

作者: S. Schmid , W. Uhl , M. W. Büchler

DOI: 10.3109/00365529609105000

关键词: ProteasesGastroenterologyAcute pancreatitisAnimal studiesFresh frozen plasmaInternal medicineProteasePathogenesisDiseaseAprotininMedicineIntensive care medicine

摘要: A number of pancreatic enzymes have been suggested as the initiating factor for acute pancreatitis. In particular, relationship between proteases and antiproteases has examined extensively, based on suspicion that an imbalance them is central in pathogenesis Animal studies with antiproteolytic agents models pancreatitis shown improvement outcome. However, more recently, prospective, randomized, multicentre trials treating human drugs (aprotinin, gabexate mesilate, even fresh frozen plasma) failed to show any benefit clinical setting. Thus, clinically, it seems likely therapy no effect course severe Today, mortality determined by septic complications due infected necroses late phase 2–3 weeks after onset disease. Death early disea...

参考文章(26)
C. Figarella, M. Amouric, O. Guy-Crotte, Enzyme Activation and Liberation: Intracellular/Extracellular Events Acute Pancreatitis. pp. 53- 60 ,(1987) , 10.1007/978-3-642-83027-3_8
Peter Malfertheiner, Markus Büchler, Hans G. Beger, Cornelia Schoetensack, Waldemar Uhl, Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study International Journal of Pancreatology. ,vol. 1, pp. 227- 235 ,(1986) , 10.1007/BF02795248
J. P. Neoptolemos, M. Holliday, M. Watkins, A. Attard, C. Hall, T. Leese, W. M. Thomas, A multicentre controlled clinical trial of high-volume fresh frozen plasma therapy in prognostically severe acute pancreatitis. Annals of The Royal College of Surgeons of England. ,vol. 73, pp. 207- 214 ,(1991)
Markus Büchler, Peter Malfertheiner, Waldemar Uhl, Jürgen Schölmerich, Fritz Stöckmann, Guido Adler, Wilhelm Gaus, Klaus Rolle, Hans G Beger, German Pancreatitis Study Group, None, Gabexate mesilate in human acute pancreatitis Gastroenterology. ,vol. 104, pp. 1165- 1170 ,(1993) , 10.1016/0016-5085(93)90288-N
C. W. Imrie, I. S. Benjamin, J. C. Ferguson, A. J. McKay, I. Mackenzie, J. O'Neill, L. H. Blumgart, A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis British Journal of Surgery. ,vol. 65, pp. 337- 341 ,(2005) , 10.1002/BJS.1800650514
Michael J. McMahon, Margaret Bowen, Anthony D. Mayer, Edward H. Cooper, Relation of α2-macroglobulin and other antiproteases to the clinical features of acute pancreatitis American Journal of Surgery. ,vol. 147, pp. 164- 170 ,(1984) , 10.1016/0002-9610(84)90052-7
Michael L. Steer, Jacopo Meldolesi, Catherine Figarella, Pancreatitis Digestive Diseases and Sciences. ,vol. 29, pp. 934- 938 ,(1984) , 10.1007/BF01312483
B. Hesse, P.G. Lankisch, H. Kunze, Effects of the serine protease inhibitor gabexate mesilate on purified pancreatic phospholipase A2 Pharmacological Research Communications. ,vol. 16, pp. 637- 645 ,(1984) , 10.1016/S0031-6989(84)80042-9